Patents
Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
11/2007
11/08/2007WO2007125034A2 Mono-nitration of aromatic compounds
11/08/2007WO2007124832A1 4-amino-2,6-dimethylphenol compound, process for its preparation and pharmaceutical composition comprising the same
11/08/2007WO2007107352A8 Agents that disrupt cellular replication and their use in inhibiting pathological conditions
11/08/2007WO2007052023A3 Novel compounds
11/08/2007WO2006095263A8 Substituted n-sulfonylaminophenylethyl-2-phenoxy acetamide compounds
11/08/2007US20070259961 Novel acyl urea, thiourea, carbamate, thiocarbamate and related compounds are provided which are effective in inhibiting the cytokine-mediated inflammatory response in cultured cells, in ameliorating bone destruction in an animal model of arthritis and in lowering blood glucose levels in animal or cancer
11/08/2007US20070259863 Arylphenylamino-,Arylphenylamide-, and Arylphenylether-Sulfide Derivatives
11/08/2007US20070259774 Enantioselective Phosphoramidite Compounds and Catalysts
11/08/2007CA2650914A1 Compounds that are agonists of muscarinic receptors and that may be effective in treating pain, alzheimer's disease and/or schizophrenia
11/08/2007CA2650683A1 Amine derivative having npy y5 receptor antagonist activity
11/07/2007EP1852422A2 Nitrosated and nitorsylated alpha-andrenergic receptor antagonist compounds, compositions and their uses
11/07/2007EP1851210A2 Nitro-substituted phenyl-piperazine compounds, their preparation and use in medicaments
11/07/2007EP0833624B1 Prevention and treatment of cardiovascular pathologies with tamoxifen analogues
11/07/2007CN101068798A Crystal and salt of 1-cyclopropylmethyl-4-[2-(3,3,5,5)-tetramethylcyclohexyl)phenyl]piperazine
11/07/2007CN101068791A Method for preparing salt with tetrafluoroborate anion and reducing the content of hologenate
11/07/2007CN101068789A Novel intermediates useful for the preparation of aripiprazole and methods for the preparation of the novel intermediates and aripiprazole
11/07/2007CN101068773A Melanin concentrating hormone antagonists
11/07/2007CN101068772A N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds
11/07/2007CN101066955A Synthesis proces sof N-methyl morpholine
11/07/2007CN100347162C N-苯基-2-嘧啶胺衍生物 N- phenyl-2-pyrimidine-amine derivative
11/07/2007CN100347151C Novel aminobenzoephenones
11/06/2007USRE39916 Compounds that modulate PPAR activity and methods for their preparation
11/06/2007US7291654 Storage stability of photoinitiators
11/06/2007US7291620 N-alkyl phenylcarboxamide beta-secretase inhibitors for the treatment of Alzheimer's disease
11/06/2007US7291617 Arylamidine derivative or salt thereof
11/06/2007CA2223112C 1,2-bis-adducts of stable nitroxides with substituted ethylenes and stabilized compositions
11/06/2007CA2183368C Racemization-free dehalogenation of halo-substituted arylalkylamines
11/01/2007WO2007123718A1 1-HETEROCYCLYLAMINO-2-HYDROXY-3-AMINO-ω-ARYLALKANES
11/01/2007WO2007087135A3 PIPERAZINES AND PIPERIDINES AS mGluR5 POTENTIATORS
11/01/2007WO2007072092A3 New phenanthridine derivatives as bradykinin antagonists
11/01/2007WO2007053386A3 Processes for the preparation of cyclopropyl-amide derivatives
11/01/2007WO2007047146A3 Inhibitors of viral replication
11/01/2007US20070255056 Method for manufacture of compounds related to the class of substituted sulfonyl urea anti-diabetics
11/01/2007US20070254916 Aryl and heteroaryl compounds, compositions, and methods of use
11/01/2007US20070254890 4(Phenyl-Piperazinyl-Methyl) Benzamide Derivatives and Their Use for the Treatment of Pain or Gastrointestinal Disorders
11/01/2007US20070254875 Androgen Receptor Modulator Compounds and Methods
11/01/2007US20070254822 Method for Producing Quaternary Ammonium Compounds
10/2007
10/31/2007EP1849469A1 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders
10/31/2007EP1848707A1 Awthranilic acid derivatives and their use in treatment of diseases of lipid metabolism, in particular dyslipidaemia
10/31/2007EP1745056A4 Enantioselective phosphoramidite compounds and catalysts
10/31/2007EP1318980B1 Hydroxamate derivatives useful as deacetylase inhibitors
10/31/2007EP1246795B1 Antibacterial agents
10/31/2007EP1144384B1 Compounds which inhibit leukocyte adhesion mediated by vla-4
10/31/2007EP0910564B1 D-amino acid derived inhibitors of cysteine and serine proteases
10/31/2007CN101062923A Synthesizing N-formyl morpholine by two-step process
10/31/2007CN101062922A Method for preparing N-formyl morpholine
10/31/2007CN101062921A Preparation method of 3-(4-chlorphenyl)-3-(3,4-dialkoxyphenyl)acryloyl morpholine
10/31/2007CN100345834C 异羟肟酸衍生物 Hydroxamic acid derivatives
10/31/2007CN100345833C Modulators of dopamine neurotransmission
10/30/2007US7288671 Perhydro- or hydrophenanthrene derivatives; antiinflammatory, analgesic, anticarcinogenic, and antitumor agents; , autoimmune, skin, cardiovascular, and viral diseases
10/30/2007US7288571 Thyroid receptor ligands and method II
10/30/2007US7288567 Inhibitors of histone deacetylase
10/30/2007US7288566 Inhibit 20-hydroxyeicosatetraenoic acid (20-HETE)-producing enzymes; kidney disease
10/30/2007US7288540 Phenylalkynes
10/30/2007CA2320627C Medicament for treatment of diastolic dysfunction
10/30/2007CA2264002C Naphthyl compounds, intermediates, compositions, and methods of use
10/25/2007WO2007120647A2 Compositions useful as inhibitors of voltage-gated sodium channels
10/25/2007WO2007118964A1 Substituted n-(phenethyl)benzamide derivatives, preparation and uses thereof
10/25/2007WO2007101864A3 Compounds that modulate ppar activity, their preparation and use
10/25/2007WO2006103342A9 Indanyl-piperazine derivatives, method for preparing same and pharmaceutical compositions containing same
10/25/2007US20070249829 Method for the Synthesis of Exocyclic Derivatives of Cycloalkyl-Hydrazines and Exocyclic Derivatives of Heterocycloalkyl-Hydrazines
10/25/2007US20070249826 Method for the preparation of 21-hydroxy-6,19-oxidoprogesterone (21oh-6op)
10/25/2007US20070249688 3-{4-[1-(4'-tert-butyl-2,6-dimethyl-biphenyl-4-yloxy)-4,4,4-trifluoro-butyl]-benzoylamino}-propionic acid; treat diabetic and other glucagon related metabolic disorders
10/25/2007US20070249686 Modulators of Crth-2 Receptor Activity for the Treatment of Prostaglandin D2 Mediated Diseases
10/25/2007US20070249619 Diarylmethyl Piperazine Derivatives, Preparations Thereof and Uses Thereof
10/25/2007US20070249618 Novel Piperidine Derivatives as Histamine H3 Receptor Ligands for Treatment of Depression
10/25/2007US20070249591 Biaryl Amino Acids and Their Use in Dna Binding Oligomers
10/25/2007DE102006018345A1 Aufhell- und/oder Färbemittel mit Amidinen Reducing and / or coloring with amidines
10/25/2007CA2648202A1 Compositions useful as inhibitors of voltage-gated sodium channels
10/24/2007EP1847527A1 Novel benzamidine compound
10/24/2007EP1846385A2 An exo-selective synthesis of himbacine analogs
10/24/2007EP1846384A1 Monohydrochloride salt of 1-[3-[3-(4-chlorophenyl)propoxy]propyl]-piperidine
10/24/2007EP1846375A1 2-amino-1-phenylethylcarboxamide derivatives
10/24/2007EP1846372A2 Compounds for inflammation and immune-related uses
10/24/2007EP1846366A1 Norvaline derivative and method for preparation thereof
10/24/2007EP1846361A2 3-amino-2-aminomethylphenol derivatives and colorants comprising these compounds
10/24/2007EP1846347A1 Method for the use of [11c] carbon monoxide in labeling synthesis of 11c-labelled compounds by thermally induced free radical carbonylation
10/24/2007CN101061090A Process for producing alpha, alpha-difluoroamine
10/24/2007CN101058568A Novel medicinal salt for cinepazide and preparation method thereof
10/24/2007CN101058567A Novel pharmacology acceptable salt for cinepazide
10/24/2007CN101058566A Novel medicinal salt for cinepazide and preparation method thereof
10/24/2007CN101058565A Stable cinepazide water-soluble salt
10/23/2007US7285681 Biguanide derivatives
10/23/2007US7285664 Heterocyclic or benzenic derivatives of lipoic acid, their preparation and their use as medicaments
10/23/2007US7285568 Substituted p-(2-alkoxy-2-acylethyl)biphenyl compounds, e.g., 1-[4'-(2-ethoxy-3-morpholin-4-yl-3-oxopropyl)biphenyl-3-yl]-3-heptyl-1-methylurea; useful in human or veterinary medicine: dermatology, cardiovascular diseases, immune diseases, and diseases associated with lipid metabolism
10/23/2007US7285553 Serotonergic 5HT7 receptor compounds for treating ocular and CNS disorders
10/23/2007US7285547 E.g., N'-hydroxy-3-((1-((2-methyl-1-piperidinyl)carbonyl)-2-(2 -naphthylsulfonyl)hydrazino)methyl)benzenecarboximidamide
10/23/2007CA2155472C Tertiary amines having carbonate and urethane groups
10/18/2007WO2007118137A1 Benzamide derivatives as inhibitors of histone deacetylase
10/18/2007WO2007117981A2 Selective hydroxamate based mmp inhibitors
10/18/2007WO2007116284A1 Process for preparing linezolid
10/18/2007WO2007115935A1 11β-HYDROXYSTEROID DEHYDROGENASE TYPE 1 ACTIVE COMPOUNDS
10/18/2007WO2007054257A3 Indene derivatives, their preparation and use as medicaments
10/18/2007US20070244333 Method for preparing prostaglandin derivative
10/18/2007US20070244210 Piperazino Sensitisers
10/18/2007US20070244198 Carboxylic Derivatives
10/18/2007US20070244197 Bactericide against gramnegative bacteria; respiratory system disorders
10/18/2007US20070244161 Novel mercaptophenyl naphthyl methane compounds and synthesis thereof
10/18/2007US20070244117 Novel Hydroxamic Acid Esters and Pharmaceutical Use Thereof
10/18/2007US20070244108 Phenylsulfonamide Derivatives for Use as 11-Beta-Hydroxysteroid Dehydrogenase Inhibitors
1 ... 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 ... 341